RecruitingNCT07689331

Hungarian National Systemic Amyloidosis Registry

Hungarian National Systemic Amyloidosis Registry (AMYREG) - A Multi-Center, Longitudinal, Observational Survey of Patients With Systemic Amyloidosis

Sponsor

Semmelweis University

Enrollment

300 participants

Start Date

Mar 8, 2026

Study Type

OBSERVATIONAL

Conditions

AL Amyloidosis Amyloid Cardiomyopathy ATTR Amyloidosis Systemic Amyloidosis

Summary

This registry is an observational, multicenter, retrospective and prospective, non-pharmacological study designed to collect and analyze data from patients with systemic amyloidosis treated in inpatient and outpatient cardiology, hematology, nephrology, and neurology departments across Hungary. The registry was established in 2025.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with al amyloidosis, attr amyloidosis, and other related conditions. The study is currently recruiting participants at 12 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(12)

Balatonfüredi Állami Szívkórház

Balatonfüred, Hungary

Budapesti Szent Margit Kórház

Budapest, Hungary

Budapesti Péterfy Sándor utcai Kórház - Rendelőintézet

Budapest, Hungary

Department of Internal Medicine and Hematology, Semmelweis University

Budapest, Hungary

Gottsegen National Cardiovascular Center

Budapest, Hungary

Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet

Budapest, Hungary

Dél-budai Centrumkórház Szent Imre Egyetemi Oktatókórház

Budapest, Hungary

Észak-Pesti Centrumkórház - Honvédkórház

Budapest, Hungary

Clinical Centre, University of Debrecen

Debrecen, Hungary

Pécsi Tudományegyetem

Pécs, Hungary

Szegedi Tudományegyetem

Szeged, Hungary

Fejér Vármegyei Szent György Egyetemi Oktató Kórház

Székesfehérvár, Hungary

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07689331

Related Trials

A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis

NCT059518161 location

The Norwegian Immunotherapy in Multiple Myeloma Study

NCT0685512123 locations

OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

NCT0635593429 locations

Optimize First-line Treatment for AL Amyloidosis With t (11; 14)

NCT061929797 locations

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

NCT06563895103 locations